130 related articles for article (PubMed ID: 25801197)
1. Metabolic syndrome and the risk of Barrett's oesophagus in white males.
Thrift AP; Hilal J; El-Serag HB
Aliment Pharmacol Ther; 2015 Jun; 41(11):1182-9. PubMed ID: 25801197
[TBL] [Abstract][Full Text] [Related]
2. Statin use is associated with a decreased risk of Barrett's esophagus.
Nguyen T; Khalaf N; Ramsey D; El-Serag HB
Gastroenterology; 2014 Aug; 147(2):314-23. PubMed ID: 24798416
[TBL] [Abstract][Full Text] [Related]
3. Protective role of gluteofemoral obesity in erosive oesophagitis and Barrett's oesophagus.
Rubenstein JH; Morgenstern H; Chey WD; Murray J; Scheiman JM; Schoenfeld P; Appelman HD; McMahon L; Metko V; Kellenberg J; Kalish T; Baker J; Inadomi JM
Gut; 2014 Feb; 63(2):230-5. PubMed ID: 23461896
[TBL] [Abstract][Full Text] [Related]
4. Association of insulin and insulin-like growth factors with Barrett's oesophagus.
Greer KB; Thompson CL; Brenner L; Bednarchik B; Dawson D; Willis J; Grady WM; Falk GW; Cooper GS; Li L; Chak A
Gut; 2012 May; 61(5):665-72. PubMed ID: 21930730
[TBL] [Abstract][Full Text] [Related]
5. The use of nonsteroidal anti-inflammatory drugs and the risk of Barrett's oesophagus.
Thrift AP; Pandeya N; Smith KJ; Green AC; Webb PM; Whiteman DC
Aliment Pharmacol Ther; 2011 Nov; 34(10):1235-44. PubMed ID: 21967506
[TBL] [Abstract][Full Text] [Related]
6. The association of body mass index with Barrett's oesophagus.
Stein DJ; El-Serag HB; Kuczynski J; Kramer JR; Sampliner RE
Aliment Pharmacol Ther; 2005 Nov; 22(10):1005-10. PubMed ID: 16268976
[TBL] [Abstract][Full Text] [Related]
7. Dietary consumption of meat, fat, animal products and advanced glycation end-products and the risk of Barrett's oesophagus.
Jiao L; Kramer JR; Chen L; Rugge M; Parente P; Verstovsek G; Alsarraj A; El-Serag HB
Aliment Pharmacol Ther; 2013 Oct; 38(7):817-24. PubMed ID: 23957669
[TBL] [Abstract][Full Text] [Related]
8. Risk Profiles for Barrett's Esophagus Differ between New and Prevalent, and Long- and Short-Segment Cases.
Tan MC; Murrey-Ittmann J; Nguyen T; Ketwaroo GA; El-Serag HB; Thrift AP
PLoS One; 2016; 11(12):e0169250. PubMed ID: 28036381
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis: Barrett's oesophagus and the risk of colonic tumours.
Andrici J; Tio M; Cox MR; Eslick GD
Aliment Pharmacol Ther; 2013 Feb; 37(4):401-10. PubMed ID: 23163592
[TBL] [Abstract][Full Text] [Related]
10. Leptin and the risk of Barrett's oesophagus.
Kendall BJ; Macdonald GA; Hayward NK; Prins JB; Brown I; Walker N; Pandeya N; Green AC; Webb PM; Whiteman DC;
Gut; 2008 Apr; 57(4):448-54. PubMed ID: 18178609
[TBL] [Abstract][Full Text] [Related]
11. Oral bisphosphonates and the risk of Barrett's esophagus: case-control analysis of US veterans.
Lin D; Kramer JR; Ramsey D; Alsarraj A; Verstovsek G; Rugge M; Parente P; Graham DY; El-Serag HB
Am J Gastroenterol; 2013 Oct; 108(10):1576-83. PubMed ID: 23857477
[TBL] [Abstract][Full Text] [Related]
12. Waist-to-hip ratio, but not body mass index, is associated with an increased risk of Barrett's esophagus in white men.
Kramer JR; Fischbach LA; Richardson P; Alsarraj A; Fitzgerald S; Shaib Y; Abraham NS; Velez M; Cole R; Anand B; Verstovsek G; Rugge M; Parente P; Graham DY; El-Serag HB
Clin Gastroenterol Hepatol; 2013 Apr; 11(4):373-381.e1. PubMed ID: 23220167
[TBL] [Abstract][Full Text] [Related]
13. Total body fat and the risk of Barrett's oesophagus - a bioelectrical impedance study.
Kendall BJ; Macdonald GA; Prins JB; O'Brien S; Whiteman DC;
Cancer Epidemiol; 2014 Jun; 38(3):266-72. PubMed ID: 24726825
[TBL] [Abstract][Full Text] [Related]
14. Physical activity and the risk of Barrett's esophagus.
Hilal J; El-Serag HB; Ramsey D; Ngyuen T; Kramer JR
Dis Esophagus; 2016 Apr; 29(3):248-54. PubMed ID: 25715656
[TBL] [Abstract][Full Text] [Related]
15. Barrett's oesophagus is not a risk factor for colonic neoplasia: a case-control study.
Laitakari R; Laippala P; Isolauri J
Ann Med; 1995 Aug; 27(4):499-502. PubMed ID: 8519512
[TBL] [Abstract][Full Text] [Related]
16. Reduced expression of αGlcNAc in Barrett's oesophagus adjacent to Barrett's adenocarcinoma--a possible biomarker to predict the malignant potential of Barrett's oesophagus.
Iwaya Y; Hasebe O; Koide N; Kitahara K; Suga T; Shinji A; Muraki T; Yokosawa S; Yamada S; Arakura N; Tanaka E; Nakayama J
Histopathology; 2014 Mar; 64(4):536-46. PubMed ID: 24117499
[TBL] [Abstract][Full Text] [Related]
17. Association of metabolic syndrome with erosive esophagitis and Barrett's esophagus in a Chinese population.
Lee SW; Lien HC; Chang CS; Lee TY; Peng YC; Yeh HZ
J Chin Med Assoc; 2017 Jan; 80(1):15-18. PubMed ID: 27756532
[TBL] [Abstract][Full Text] [Related]
18. Alcohol consumption pattern and risk of Barrett's oesophagus and erosive oesophagitis: an Italian case-control study.
Filiberti RA; Fontana V; De Ceglie A; Blanchi S; Grossi E; Della Casa D; Lacchin T; De Matthaeis M; Ignomirelli O; Cappiello R; Rosa A; Foti M; Laterza F; D'Onofrio V; Iaquinto G; Conio M
Br J Nutr; 2017 Apr; 117(8):1151-1161. PubMed ID: 28478792
[TBL] [Abstract][Full Text] [Related]
19. Does Barrett's oesophagus develop over time in patients with chronic gastro-oesophageal reflux disease?
Stoltey J; Reeba H; Ullah N; Sabhaie P; Gerson L
Aliment Pharmacol Ther; 2007 Jan; 25(1):83-91. PubMed ID: 17229223
[TBL] [Abstract][Full Text] [Related]
20. Central adiposity and risk of Barrett's esophagus.
Edelstein ZR; Farrow DC; Bronner MP; Rosen SN; Vaughan TL
Gastroenterology; 2007 Aug; 133(2):403-11. PubMed ID: 17681161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
